8 results in Exploration of Medicine
Latest
  • Latest
  • Most Viewed
  • Most Downloaded
  • Most Cited
Sort by :
Open Access Review
The potential anti-cancer effects of melatonin on breast cancer
Naba Kumar Das, Saptadip Samanta
Published: February 25, 2022 Explor Med. 2022;3:112–127
41625 356 7
Open Access Original Article
Placental CD4+ T cells from preeclamptic patients cause autoantibodies to the angiotensin II type I receptor and hypertension in a pregnant rat model of preeclampsia
Kristin E. Reeve ... Babbette LaMarca
Published: February 25, 2022 Explor Med. 2022;3:99–111
This article belongs to the special issue Angiotensins—A Century of Progress
4373 67 18
Open Access Review
Multi-faced roles of reactive oxygen species in anti-tumor T cell immune responses and combination immunotherapy
Tao Wang, Haiyan Xu
Published: February 25, 2022 Explor Med. 2022;3:77–98
This article belongs to the special issue Reactive Oxygen Species (ROS) in Pathophysiological Conditions
10028 113 6
Open Access Editorial
Elimination of hepatitis C virus infection in Europe: targeting the obstacles
Dante Romagnoli
Published: February 24, 2022 Explor Med. 2022;3:71–76
This article belongs to the special issue Exploring Chronic Liver Disease
3563 31 1
Open Access Review
Oxidative stress in obesity and insulin resistance
Anastasija Panic ... Esma R. Isenovic
Published: February 23, 2022 Explor Med. 2022;3:58–70
This article belongs to the special issue Reactive Oxygen Species (ROS) in Pathophysiological Conditions
14705 312 40
Open Access Review
Reactive oxygen species in cancer progression and its role in therapeutics
Ranjeet Singh, Partha Pratim Manna
Published: February 22, 2022 Explor Med. 2022;3:43–57
This article belongs to the special issue Reactive Oxygen Species (ROS) in Pathophysiological Conditions
24029 497 72
Open Access Review
Nano-immunotherapeutics: targeting approach as strategic regulation at tumor microenvironment for cancer treatment
Priyanka Singh ... Anita Kamra Verma
Published: February 16, 2022 Explor Med. 2022;3:22–42
This article belongs to the special issue Nanomedicine and Cancer Immunotherapy
5234 60 3